Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women

Journal of Medical Virology

Volumn 66, Issue 4, 2002, Pages 535-541

  Forslund, Ola ^a,h   Antonsson, Annika ^a   Edlund, Karin ^c   Van Den Brule, Adrian J C ^b   Hansson, Bengt Göran ^a   Meijer, Chris J L M ^b   Ryd, Walter ^f   Rylander, Eva ^e   Strand, Anders ^d   Wadell, Göran ^c   Dillner, Joakim ^a   Johansson, Bo ^g  

^a LUND UNIVERSITY   (Sweden)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UMEÅ UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e DANDERYD HOSPITAL   (Sweden)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cervical screening; HPV; PCR EIA

Indexed keywords

PRIMER DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOT HYBRIDIZATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MASS SCREENING; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; SWEDEN; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

ADULT; CERVIX UTERI; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; PREVALENCE; SWEDEN; TUMOR VIRUS INFECTIONS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRUS;

EID: 0036194578     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.2178     Document Type: Article

References (36)

1. A cohort study of cervical cancer screening in British Columbia
2. Reasons that some screening programmes fail to control cervical cancer
3. Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay
4. A systematic review of the role of human papillomavirus testing within a cervical screening programme
5. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: The age-related pattern
6. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR
7. Human papillomavirus DNA in women without and with cytological abnormalities: Results of a 5-year follow-up study
8. Human papillomavirus infection is transient in young women: A population-based cohort study
9. Cervical intraepithelial neoplasia and condyloma: An analysis of diagnostic accuracy of posttreatment follow-up methods
10. Typing of human papillomaviruses by consensus polymerase chain reaction and a non-radioactive reverse dot blot hybridization
11. Human papilloma virus types in routine cytological screening and at colposcopic examinations
12. Persistence of type-specific human papillomavirus infection among cytologically normal women
13. Natural history of cervicovaginal papillomavirus infection in young women
14. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia
15. +-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings
16. Reliable high risk HPV DNA testing by polymerase chain reaction: An intermethod and intramethod comparison
17. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age-related patterns for high-risk and low-risk types
18. Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes
19. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions
20. Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types
21. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent
22. Pap smear screening and changes in cervical cancer mortality in Sweden
23. Distribution of 14 high risk HPV types in cervical intraepithelial neoplasia detected by a non-radioactive general primer PCR mediated enzyme immunoassay
24. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study
25. Strategies for global control of cervical cancer
26. + primer systems
27. Human papillomavirus testing for primary screening of cervical cancer precursors
28. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
29. PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes
30. The epidemiology of cervical carcinogenesis
31. Epidemiology and biology of cervical cancer
32. Present evidence on the value of HPV testing for cervical cancer screening: A model-based exploration of the (cost-) effectiveness
33. GP5+/6+PCR followed by reverse line blot analysis enables rapid and high throughout identification of HPV genotypes, suitable for mass screening
34. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
35. Laboratory reliability of the Papanicolaou smear
36. Papillomavirus infections - A major cause of human cancers